Novo Nordisk CSO: We Believe Nextgen GLP-1 To Be Potentially Differentiated Across Efficacy, Convenience, Safety, Tolerability
Novo Nordisk CSO: We Believe Nextgen GLP-1 To Be Potentially Differentiated Across Efficacy, Convenience, Safety, Tolerability